Article
[A trial of new interferon therapy for the patients with chronic hepatitis C resistant to interferon therapy].
Nihon rinsho. Japanese journal of clinical medicine - 1 Jul 2001
Arase Y, Kumada H
Abstract excerpt
HCV-RNA clearance rates are reported to be about 30-40% of the patients treated with IFN for less than 6 months. But IFN therapy is ineffective for chronic hepatitis C patients with HCV-genotype 1b and a high virus load. We evaluated the efficacy of different IFN therapy compared with standard IFN therapy for chronic hepatitis C patients resistant to interferon therapy. That is, we assessed the following therapy;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
